Risk, returns & timeframes illustration
1 min read
April 27, 2022
by

Is the US getting potty?

Is it stubs out for marijuana law reform in the US? 🌿 Not yet but it sure is dragging. Decriminalisation laws may have passed step one but step two is looking like a major hurdle. As growers invest in, erm, growing revenue, could investors ever get the highs?
Risk, returns & timeframes illustration
1 min read
April 27, 2022
by

Is the US getting potty?

Is it stubs out for marijuana law reform in the US? 🌿 Not yet but it sure is dragging. Decriminalisation laws may have passed step one but step two is looking like a major hurdle. As growers invest in, erm, growing revenue, could investors ever get the highs?
Table of contents
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.
Weekly news from Wall St
Subscribe to The Fry Up - your weekly sizzle of headline-grabbing share market news. Read by 60,000 Kiwis to help them take charge of their investing journey.

As April’s 420 month stubs out, what’s the latest deal? In New Zealand, while gardeners weeded out growth on parliament lawns, Southland farmers have been hitting new highs in their cannabis trials, and the East Coast’s Rua Bioscience launched their first prescription medicinal marijuana product. 🧪There’s been smoke signals across the Pacific, too. US lawmakers in the House of Representatives have been stoking the fires and heating up marijuana lobbyists’ belief that full law reform is a matter of ‘not if, but when’. 

Yet despite 37 US states having medical marijuana laws and 18 with recreational cannabis laws, the wait for growers’ continues to drag as the federal prohibition rolls on. The blocker? Seems legal reform needs to blaze a trail through the Senate before sweeping federal government law changes can be made. And with just three Republicans backing decriminalisation, there’s a damper on expectations. 🚭 

It’s a problem, why? Barclays strategists last year predicted cannabis could blunt budget pain by bringing in up to US$12 billion in tax revenue. 💰 And according to cannabis trade publication MJBiz, the budding marijuana industry, which increased sales by 35% from 2020 to an estimated US$27 billion, is predicted to double in value by 2025. Meaning, relaxing weed laws could bump up the fed’s tax revenue. Perhaps a joint effort to rally the Senate needs to be on the cards? With nearly half a million people in the US having jobs connected to the cannabis industry, rallying them could be lobbyists’ next power move. 

It might be a while before investors see returns light up, however. Marijuana ETFs, including Alternative Harvest ETF (MJ), and the biggest cannabis companies, Tilray (TLRY), Aurora Cannabis (ACB), Canopy Growth Company (CGC) and Cronos (CRON), have failed to deliver for investors, instead focussing on buying new equipment to supercharge revenue growth. Looks like not even Snoop Dogg’s 14-year friendship with Martha Stewart, Canopy’s official strategic advisor, can deliver the highs. 💧

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

More recent news articles

More recent learn articles

6 min read
Nov 28, 2023

Black Friday’s record-breaking US$9.8 billion US online sales, US$70.9 billion globally

New Zealand imported Black Friday from the US, but that doesn’t mean we’re spending up large during tighter economic times. While Black Friday spending soared in the US, it seems Kiwis weren’t quite so keen to part with their hard-earned cash. So who was spending up large in record US Black Friday shopping?
Read more
6 min read
Nov 21, 2023

Underrated Thanksgiving stocks and hopes for a seasonal market rally

While 2023 may have felt like a bumpy ride for investors it seems that recession predictions were stymied by a buoyant American economy. Could the road ahead bring in fresh optimism echoing rallies of holidays past?
Read more
5 min read
Nov 14, 2023

Affirm shares surged 24% ahead of holidays splurge

In a world of instant gratification, is buy now pay later (BNPL) just what we do now? While BNPL providers aren't rapidly bringing on more customers and people aren’t using BNPL more, shoppers are missing more payments sinking into a debt cycle helping providers’ revenue to climb. Is this why Affirm’s stock has soared 153% this year?
Read more

More recent news articles

More recent learn articles

6 min read
Nov 28, 2023

Black Friday’s record-breaking US$9.8 billion US online sales, US$70.9 billion globally

New Zealand imported Black Friday from the US, but that doesn’t mean we’re spending up large during tighter economic times. While Black Friday spending soared in the US, it seems Kiwis weren’t quite so keen to part with their hard-earned cash. So who was spending up large in record US Black Friday shopping?
Read more
6 min read
Nov 21, 2023

Underrated Thanksgiving stocks and hopes for a seasonal market rally

While 2023 may have felt like a bumpy ride for investors it seems that recession predictions were stymied by a buoyant American economy. Could the road ahead bring in fresh optimism echoing rallies of holidays past?
Read more
5 min read
Nov 14, 2023

Affirm shares surged 24% ahead of holidays splurge

In a world of instant gratification, is buy now pay later (BNPL) just what we do now? While BNPL providers aren't rapidly bringing on more customers and people aren’t using BNPL more, shoppers are missing more payments sinking into a debt cycle helping providers’ revenue to climb. Is this why Affirm’s stock has soared 153% this year?
Read more